Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Cardiovascular diseases (CVDs) are the leading cause of premature deaths in the EU and account for 32% of all deaths in 2021 (over 1.7 million deaths).
Biological sex and gender play a specific role both in the incidence and the prevalence of certain diseases, including CVDs. Sex and gender disparities in CVDs are influenced by biological, behavioural, and sociocultural factors, affecting symptoms, prevalence, treatment, and outcomes. Hormonal influences, genetic predispositions, and/or physiological differences contribute to variations in how CVD presents and progresses in men and women. Risk factors such as diabetes, cholesterol, smoking, and age have different impacts across genders, highlighting the need for customised treatment strategies. Unique gender-specific conditions in women, such as menopause, pregnancy complications like preeclampsia and certain autoimmune diseases, also increase the risk for CVDs.
Mainstreaming a gender perspective into the research, prevention and control of CVDs is thus crucial to understanding and addressing the health risks and needs of women and men of all ages.
Although the significant progress has been done in investigating sex and/or gender-specific pathophysiological mechanisms of cardiovascular diseases, more research is needed to translate basic discoveries into the development of innovative prevention, detection, diagnosis, and treatment options.
Proposals should address most of the following aspects:
Proposals are encouraged to consider, where relevant, the data, expertise and services offered by European research infrastructures in the health domain.
The use and/or development of new technologies, including digital ones (e.g. (generative) Artificial Intelligence) that support research under this topic is encouraged.
Disease progression and overall health status at different life stages, as well as hormonal influences, genetic factors, etc. and psychosocial, socioeconomic, cultural and behavioural factors should be considered in the proposed research. Other intersecting factors such as racial or ethnic origin, often amplify existing inequalities in health access and outcomes. Proposals should, where relevant, consider these to design effective and inclusive interventions.
In the context of gender-specific research, this topic requires the effective contribution of social sciences and humanities (SSH) disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities.
The participation of start-ups, micro, small and medium-sized enterprises (SMEs) is encouraged with the aim of strengthening their scientific and technological foundations, enhancing their innovation potential, and exploring possibilities for commercial exploitation.
All projects funded under this topic are encouraged to participate in networking and joint activities, as appropriate. Proposals should include a budget for the attendance to regular joint meetings and may consider covering the costs of any other potential joint activities without the prerequisite to detail concrete joint activities at this stage. The details of these joint activities will be defined during the grant agreement preparation phase. All projects funded under this topic are also encouraged to explore complementarities and exploit potential synergies with the projects funded under topic HORIZON-CL6-2026-02-FARM2FORK-10: “Sustainable and healthy diets based on health status and socio-economic risk factors of ageing population”, once information on the funded projects is available.
All projects funded under this topic are encouraged to explore potential synergies with projects to be funded under the EU4Health Work Programme 2026 related to the gender and CVDs.
Applicants envisaging to include clinical studies should provide details of their clinical studies in the dedicated annex using the template provided in the submission system.
100%
Expected EU contribution per project: between €6.00 million and €7.00 million.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).
Subject to restrictions for the protection of European communication networks.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects.
Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia,
P.B. 23422, 1683 Nicosia
Telephone: +357 22205000
Fax: +357 22205001
Email: support@research.org.cy
Website: https://www.research.org.cy/en/
Contact Person:
George Christou
Scientific Officer
Email: gchristou@research.org.cy